Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi | Journal of Clinical Oncology
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
Novel prognostic scoring system for diffuse large B-cell lymphoma
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphoma - Cancer Genetics
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Cox univariate and multivariate analyses of prognostic factors of... | Download Scientific Diagram
Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Diffuse Large B-cell Lymphoma Prognosis Calculator
Immunohistochemical Distinction Between Diffuse Large B-Cell... | Download Table
Diffuse Large B-cell Lymphoma Prognosis Calculator
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
H&E and immunohistochemical stain images of 209 cases of diffuse large B-cell lymphoma linked with cytogenetic features and clinical outcomes (DLBCL-Morphology) - The Cancer Imaging Archive (TCIA) Public Access - Cancer Imaging
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Diffuse large B cell lymphoma: Outlook, stages, treatment
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
CDHB Red Book
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
![The International Prognostic Index (IPI) [117] and age-adjusted IPI... | Download Table](https://www.researchgate.net/profile/Felicitas-Hitz-2/publication/221792047/figure/tbl1/AS:669693157335055@1536678699331/The-International-Prognostic-Index-IPI-117-and-age-adjusted-IPI-118-for.png "The International Prognostic Index (IPI) [117] and age-adjusted IPI... | Download Table")